Type B insulin resistance syndrome.
Willard DL, Stevenson M, Steenkamp D.
Curr Opin Endocrinol Diabetes Obes. 2016 Aug;23(4):318-23. doi: 10.1097/MED.0000000000000263.
New classification and diagnostic criteria for insulin resistance syndrome.
Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, Yorifuji T, Katagiri H.
Endocr J. 2022 Feb 28;69(2):107-113. doi: 10.1507/endocrj.EJ21-0725. Epub 2022 Feb 1.
Epidemiology of Hepatocellular Carcinoma.
McGlynn KA, Petrick JL, El-Serag HB.
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature.
Iseri K, Iyoda M, Shikida Y, Inokuchi T, Morikawa T, Hara N, Hirano T, Shibata T.
Diabet Med. 2017 Dec;34(12):1788-1791. doi: 10.1111/dme.13524.
Type B insulin resistance syndrome: A case report.
Sollier M, Vigouroux C, Duckett K, Auclair M, Lamand V, Nassouri S, Garcia C, Bordier L, Caré W.
Diabetes Metab. 2024 Sep;50(5):101549. doi: 10.1016/j.diabet.2024.101549. Epub 2024 Jun 22.
PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism.
Rius-Pérez S, Torres-Cuevas I, Millán I, Ortega ÁL, Pérez S.
Oxid Med Cell Longev. 2020 Mar 9;2020:1452696. doi: 10.1155/2020/1452696. eCollection 2020.
muetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.
Byrne CD, Armandi A, Pellegrinelli V, Vidal-Puig A, Bugianesi E.
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):314-328. doi: 10.1038/s41575-025-01045-z. Epub 2025 Feb 17.
Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
Wimalawansa SJ.
J Steroid Biochem Mol Biol. 2018 Jan;175:177-189. doi: 10.1016/j.jsbmb.2016.09.017. Epub 2016 Sep 20.
Type 1 diabetes and subcutaneous insulin resistance syndrome treated with pancreas transplantation.
Rueda DA, Reissig F, Leanza M, Aguirre R, Contardo D, Hernández S, Di Fonzo H, Finocchietto P.
Medicina (B Aires). 2021;81(5):843-845.
A typical presentation of type B insulin resistance syndrome with isolated hypoglycaemia and suppressed insulin.
Brown N, Du Toit S, Conaglen J, Elston M.
BMJ Case Rep. 2022 Feb 19;15(2):e246523. doi: 10.1136/bcr-2021-246523.
